The CSL share price is up 25% in 12 months

The CSL Limited (ASX:CSL) share price is up 25% in 12 months. Is it too late to invest?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

On Thursday the CSL Limited (ASX: CSL) share price dropped 1% lower to finish the day at $1.99.

Despite this small decline, the biotherapeutics company's shares are up an impressive 25% over the last 12 months.

Why is the CSL share price up 25% in 12 months?

The CSL share price has been on fire over the last 12 months thanks to an impressive performance in FY 2018 and an equally positive start to FY 2019.

The company posted a net profit after tax of US$1,729 million in FY 2018, which was up by 29% on the prior corresponding period. This was driven by strong sales of its Privigen, Hizentra, and IDELVION products and supported by the launch of the HAEGARDA product.

The good news for shareholders is that the positive momentum has carried over into FY 2019 with the company releasing a solid half year result in February.

CSL posted a 9% increase in total half year revenue to US$4.5 billion and a 7% (10% in constant currency) increase in net profit after tax to US$1.2 billion.

The strong top line growth was the result of an 8% lift in revenue by its CSL Behring business and a 21% jump in revenue by its fledgling Seqirus influenza business.

Pleasingly, management also provided guidance which indicates that the second half will be even stronger.

It advised that the company is trending towards the upper end of its full year profit guidance range of US$1,880 million to US$1,950 million, which will mean year on year growth of approximately 13%.

Is it too late to invest?

Although its shares are not cheap at 33x estimated forward earnings, I think the quality of the business and its strong long term growth potential makes it deserving of this premium.

As a result, despite its strong share price rally over the 12 months, I would still class CSL as a buy along with fellow healthcare shares Cochlear Limited (ASX: COH) and ResMed Inc. (ASX: COH).

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. and CSL Ltd. The Motley Fool Australia has recommended Cochlear Ltd. and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Man with rocket wings which have flames coming out of them.
Share Gainers

Guess which ASX All Ords stock just rocketed 34% on strong earnings growth

Investors just sent this ASX All Ords stock surging 34%. Here’s what’s happening.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Share Gainers

Why Dimerix, Newmont, Regal Partners, and Titomic shares are storming higher

These shares are having a good finish to the week. Let's see why.

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Share Gainers

Why Fortescue, Lynas, PEXA, and Regis Healthcare shares are charging higher

These shares are having a strong session on Thursday. But why?

Read more »

A young man talks tech on his phone while looking at a laptop. A financial graph is superimposed across the image.
Share Gainers

Why Capricorn Metals, Insignia, Perseus Mining, and Qoria shares are storming higher

These shares are having a strong session on Tuesday. But why?

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Amaero, AMP, Block, and South32 shares are racing higher today

These shares are starting the week on a positive note. But why?

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another momentous session for ASX shares this Friday.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Share Gainers

Why BHP, Catalyst Metals, Mesoblast, and Pilbara Minerals shares are shooting higher

These shares are ending the week with a bang. But why?

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

The Mesoblast share price just rocketed 38%! Here's why

ASX investors just sent the Mesoblast share price up 38%. But why?

Read more »